Published 09/27/2024 12:00:15 p.m.

$31M Provincial Investment Boosts Canada’s Immuno-Engineering and Biomanufacturing Hub at UBC

Summary by Science in Vancouver

UBC researchers at Canada’s Immuno-Engineering and Biomanufacturing Hub (CIEBH) have been awarded more than $31.4 million in provincial funding for three projects that will accelerate the development of advanced vaccines and therapeutics in British Columbia for all Canadians. The investment through the BC Knowledge Development Fund (BCKDF) supports cutting-edge research infrastructure, including the creation of an Advanced Therapeutics Manufactu…

0 Articles

All

Left

Center

Right

Science in Vancouver

$31M Provincial Investment Boosts Canada’s Immuno-Engineering and Biomanufacturing Hub at UBC

09/27/2024 12:00:15 p.m.

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center0Last Updated09/27/2024 2:45:26 p.m.Bias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

$31M Provincial Investment Boosts Canada’s Immuno-Engineering and Biomanufacturing Hub at UBC

0 Articles

0 Articles

$31M Provincial Investment Boosts Canada’s Immuno-Engineering and Biomanufacturing Hub at UBC

$31M Provincial Investment Boosts Canada’s Immuno-Engineering and Biomanufacturing Hub at UBC

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics